within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A07E_IntestinalAntiinflammatoryAgents.A07EC02_Mesalazine;

model Mesalazine
  extends Pharmacolibrary.Drugs.ATC.A.A07EC02;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A07EC02</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Mesalazine (also known as mesalamine or 5-aminosalicylic acid) is an anti-inflammatory drug used to treat inflammatory bowel diseases such as ulcerative colitis and Crohn's disease. It is approved and widely used today, primarily for induction and maintenance of remission in these conditions.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for healthy adults after single oral dose administration of mesalazine slow-release formulation.</p><h4>References</h4><ol><li><p>Zhang, Y, et al., &amp; Zuo, Z (2022). Population pharmacokinetics and IVIVC for mesalazine enteric-coated tablets. <i>Journal of controlled release : official journal of the Controlled Release Society</i> 346 275–288. DOI:<a href=&quot;https://doi.org/10.1016/j.jconrel.2022.04.024&quot;>10.1016/j.jconrel.2022.04.024</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35461968/&quot;>https://pubmed.ncbi.nlm.nih.gov/35461968</a></p></li><li><p>De Vos, M (2000). Clinical pharmacokinetics of slow release mesalazine. <i>Clinical pharmacokinetics</i> 39(2) 85–97. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200039020-00001&quot;>10.2165/00003088-200039020-00001</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10976656/&quot;>https://pubmed.ncbi.nlm.nih.gov/10976656</a></p></li><li><p>Prakash, A, &amp; Markham, A (1999). Oral delayed-release mesalazine: a review of its use in ulcerative colitis and Crohn&#x27;s disease. <i>Drugs</i> 57(3) 383–408. DOI:<a href=&quot;https://doi.org/10.2165/00003495-199957030-00013&quot;>10.2165/00003495-199957030-00013</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10193690/&quot;>https://pubmed.ncbi.nlm.nih.gov/10193690</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Mesalazine;
